Background: During the coronavirus disease (COVID-19) pandemic, an increased incidence of mucormycosis infection was noted globally, the majority being from India. We aimed to study the clinical profile of the mucormycosis patients during the COVID-19 pandemic admitted at tertiary care centers.
Materials And Methods: This is a retrospective record-based observation study conducted at Gandhi Medical College, Bhopal.